nach oben

Comparative Clinical Pathology

Erschienen in:

28.08.2018 | Original Article

Expression of interleukin-15 in canine mammary carcinoma: relationships with histologic grades, Bcl-2, recurrence, and overall survival

verfasst von: Massoud Rezaee Oghazi, Mohsen Maleki, Ahmad Reza Movassaghi, Zahra Kamyabi-Moghaddam

Erschienen in: Comparative Clinical Pathology | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Spontaneous tumors arising from mammary tissue are considered the most common tumor in female dogs and are of great importance both in veterinary and comparative medicine. Interleukin-15 is a cytokine involved in many physiologic processes such as activation of immune cells, autoimmune diseases, and cancer pathogenesis; however, the role of interleukin-15 in canine mammary cancers has not been well understood. We designed this study to examine the expression of interleukin-15 (IL-15) in canine mammary carcinoma by means of immunohistochemistry and any possible association with histologic malignancy grades, Bcl-2 expression, tumor recurrence, and overall survival. Results revealed that 14 (46.66%) of tumor samples strongly express IL-15, 7 cases (23.33%) moderately, and 9 cases showed weak immunoreactivity (30%). The expression of interleukin-15 is increased in canine mammary tumors in comparison to healthy tissues (p < 0.05). Additionally, interleukin-15 higher expression is significantly in relationship with high histologic grade (p < 0.05), high Bcl-2 expression (p < 0.05), and shorter overall survival (p < 0.05), but not with tumor recurrence (p > 0.05). Interleukin-15 could have a role mammary carcinogenesis in dogs but more studies are needed to understand its exact roles.

Faisal Adhami, Jason C Steel, Morris JC 2012 Interleukin-15 expression in lung cancer. In: ASCO Annual Meeting,

Adunyah SE, Wheeler BJ, Cooper RS (1997) Evidence for the involvement of LCK and MAP kinase (ERK-1) in the signal transduction mechanism of interleukin-15. Biochem Biophys Res Commun 232:754–758. https://doi.org/10.1006/bbrc.1997.6367 CrossRefPubMed

Bancroft GJ (1993) The role of natural killer cells in innate resistance to infection. Curr Opin Immunol 5:503–510. https://doi.org/10.1016/0952-7915(93)90030-V CrossRefPubMed

Barzegar C, Meazza R, Pereno R, Pottin-Clemenceau C, Scudeletti M, Brouty-Boyé D, Doucet C, Taoufik Y, Ritz J, Musselli C, Mishal Z, Jasmin C, Indiveri F, Ferrini S, Azzarone B (1998) IL-15 is produced by a subset of human melanomas, and is involved in the regulation of markers of melanoma progression through juxtacrine loops. Oncogene 16:2503–2512. https://doi.org/10.1038/sj.onc.1201775 CrossRefPubMed

Cory S, Huang DC, Adams JM (2003) The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 22:8590–8607. https://doi.org/10.1038/sj.onc.1207102 CrossRefPubMed

Dhillon AS, Hagan S, Rath O, Kolch W (2007) MAP kinase signalling pathways in cancer. Oncogene 26:3279–3290CrossRefPubMed

Dobbeling U, Dummer R, Laine E, Potoczna N, Qin JZ, Burg G (1998) Interleukin-15 is an autocrine/paracrine viability factor for cutaneous T-cell lymphoma cells. Blood 92:252–258PubMed

Fehniger TA, Caligiuri MA (2001) Interleukin 15: biology and relevance to human disease. Blood 97:14–32CrossRefPubMed

Gillgrass A, Gill N, Babian A, Ashkar AA (2014) The absence or overexpression of IL-15 drastically alters breast cancer metastasis via effects on NK cells, CD4 T cells, and macrophages. J Immunol 193:6184–6191. https://doi.org/10.4049/jimmunol.1303175 CrossRefPubMed

Gross A, McDonnell JM, Korsmeyer SJ (1999) BCL-2 family members and the mitochondria in apoptosis. Genes Dev 13:1899–1911CrossRefPubMed

Hodge DL, Yang J, Buschman MD, Schaughency PM, Dang H, Bere W, Yang Y, Savan R, Subleski JJ, Yin XM, Loughran TP, Young HA (2009) Interleukin-15 enhances proteasomal degradation of bid in normal lymphocytes: implications for large granular lymphocyte leukemias. Cancer Res 69:3986–3994. https://doi.org/10.1158/0008-5472.can-08-3735 CrossRefPubMedPubMedCentral

Huntington ND, Puthalakath H, Gunn P, Naik E, Michalak EM, Smyth MJ, Tabarias H, Degli-Esposti MA, Dewson G, Willis SN, Motoyama N, Huang DCS, Nutt SL, Tarlinton DM, Strasser A (2007) Interleukin 15-mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1. Nat Immunol 8:856–863. https://doi.org/10.1038/ni1487 CrossRefPubMedPubMedCentral

Ihle JN, Witthuhn BA, Quelle FW, Yamamoto K, Silvennoinen O (1995) Signaling through the hematopoietic cytokine receptors. Annu Rev Immunol 13:369–398. https://doi.org/10.1146/annurev.iy.13.040195.002101 CrossRefPubMed

Johnston JA, Bacon CM, Finbloom DS, Rees RC, Kaplan D, Shibuya K, Ortaldo JR, Gupta S, Chen YQ, Giri JD (1995) Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15. Proc Natl Acad Sci U S A 92:8705–8709CrossRefPubMedPubMedCentral

Khanna C, Lindblad-Toh K, Vail D, London C, Bergman P, Barber L, Breen M, Kitchell B, McNeil E, Modiano JF, Niemi S, Comstock KE, Ostrander E, Westmoreland S, Withrow S (2006) The dog as a cancer model. Nat Biotechnol 24:1065–1066

Kim JH, Yu CH, Yhee JY, Im KS, Sur JH (2010) Lymphocyte infiltration, expression of interleukin (IL) -1, IL-6 and expression of mutated breast cancer susceptibility gene-1 correlate with malignancy of canine mammary tumours. Journal of comparative pathology 142:177-186. https://doi.org/10.1016/j.jcpa.2009.10.023

Kumaraguruparan R, Prathiba D, Nagini S (2006) Of humans and canines: immunohistochemical analysis of PCNA, Bcl-2, p53, cytokeratin and ER in mammary tumours. Res Vet Sci 81:218–224. https://doi.org/10.1016/j.rvsc.2005.08.002 CrossRefPubMed

Kuniyasu H, Ohmori H, Sasaki T, Sasahira T, Yoshida K, Kitadai Y, Fidler IJ (2003) Production of interleukin 15 by human colon cancer cells is associated with induction of mucosal hyperplasia, angiogenesis, and metastasis. Clin Cancer Res 9:4802–4810PubMed

Lollini P-L, Palmieri G, de Giovanni C, Landuzzi L, Nicoletti G, Rossi I, Griffoni C, Frabetti F, Scotlandi K, Benini S, Baldini N, Santoni A, Nanni P (1997) Expression of interleukin 15 (IL-15) in human rhabdomyosarcoma, osteosarcoma and Ewing's sarcoma. Int J Cancer 71:732–736. https://doi.org/10.1002/(SICI)1097-0215(19970529)71:5<732::AID-IJC7>3.0.CO;2-S CrossRefPubMed

Meazza R, Verdiani S, Biassoni R, Coppolecchia M, Gaggero A, Orengo AM, Colombo MP, Azzarone B, Ferrini S (1996) Identification of a novel interleukin-15 (IL-15) transcript isoform generated by alternative splicing in human small cell lung cancer cell lines. Oncogene 12:2187–2192PubMed

Misdorp W (1999) Histological classification of mammary tumors of the dog and the cat. Armed Forces Institute of Pathology,

Misdorp W (2002) Tumors of the mammary gland. In: DJ M (ed) tumors in domestic animals. 4th edn. Iowa State Press, Ames, IA, pp 575–606, 764

Mishra A, Liu S, Sams GH, Curphey DP, Santhanam R, Rush LJ, Schaefer D, Falkenberg LG, Sullivan L, Jaroncyk L, Yang X, Fisk H, Wu LC, Hickey C, Chandler JC, Wu YZ, Heerema NA, Chan KK, Perrotti D, Zhang J, Porcu P, Racke FK, Garzon R, Lee RJ, Marcucci G, Caligiuri MA (2012) Aberrant overexpression of IL-15 initiates large granular lymphocyte leukemia through chromosomal instability and DNA hypermethylation. Cancer Cell 22:645–655. https://doi.org/10.1016/j.ccr.2012.09.009 CrossRefPubMedPubMedCentral

Mishra A, Sullivan L, Caligiuri MA (2014) Molecular pathways: Interleukin-15 signaling in health and in cancer. Clin Cancer Res 20:2044–2050. https://doi.org/10.1158/1078-0432.ccr-12-3603 CrossRefPubMedPubMedCentral

Miyazaki T et al (1994) Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. Science (New York, NY) 266:1045–1047CrossRef

Miyazaki T, Liu ZJ, Kawahara A, Minami Y, Yamada K, Tsujimoto Y, Barsoumian EL, Perlmutter RM, Taniguchi T (1995) Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation. Cell 81:223–231CrossRefPubMed

Munson L, Moresco A (2007) Comparative pathology of mammary gland cancers in domestic and wild animals. Breast Dis 28:7–21CrossRefPubMed

O'Brien MA, Kirby R (2008) Apoptosis: a review of pro-apoptotic and anti-apoptotic pathways and dysregulation in disease. J Vet Emerg Crit Care 18:572–585. https://doi.org/10.1111/j.1476-4431.2008.00363.x CrossRef

Queiroga FL, Raposo T, Carvalho MI, Prada J, Pires I (2011) Canine mammary tumours as a model to study human breast cancer: most recent findings. In Vivo 25:455–465PubMed

Rautela J, Huntington ND (2016) IL-15 signaling in NK cell cancer immunotherapy. Curr Opin Immunol 44:1–6. https://doi.org/10.1016/j.coi.2016.10.004 CrossRefPubMed

Rezaee M, Movassaghi AR, Dehghani H (2017a) Strong expression of interleukin-17 is associated with higher histologic grades in canine mammary carcinoma. Comp Clin Pathol 26:477–481. https://doi.org/10.1007/s00580-017-2403-9 CrossRef

Rezaee M, Movassaghi AR, Maleki M (2017b) Immunohistochemical expression of transforming growth factor Beta-1 in canine mammary carcinomas: its relationships with histologic grading, survival rate, and recurrence. Comparative Clinical Pathology:1-6 doi:https://doi.org/10.1007/s00580-017-2410-x

Sanders A, Ye L, Wei X, Mansel R, Jiang W (2011) P1-01-08: expression of Interleukin-15 (IL-15) and the IL-15 receptor in human breast cancer. Cancer Research 71:P1-01-08 https://doi.org/10.1158/0008-5472.sabcs11-p1-01-08

Sen B, Johnson FM (2011) Regulation of Src family kinases in human cancers. Journal of Signal Transduction 2011:14–14. https://doi.org/10.1155/2011/865819 CrossRef

Shenoy AR, Kirschnek S, Häcker G (2014) IL-15 regulates Bcl-2 family members Bim and Mcl-1 through JAK/STAT and PI3K/AKT pathways in T cells. Eur J Immunol 44:2500–2507CrossRefPubMed

Shokoohi M, Shoorei H, Soltani M, Abtahi-Eivari SH, Salimnejad R, Moghimian M (2018) Protective effects of the hydroalcoholic extract of Fumaria parviflora on testicular injury induced by torsion/detorsion in adult rats.e13047. https://doi.org/10.1111/and.13047

Shoorei H, Khaki A, Ainehchi N, Hassanzadeh Taheri MM, Tahmasebi M, Seyedghiasi G, Ghoreishi Z, Shokoohi M, Khaki AA, Abbas Raza SH (2018) Effects of Matricaria chamomilla extract on growth and maturation of isolated mouse ovarian follicles in a three-dimensional culture system. Chin Med J 131:218–225. https://doi.org/10.4103/0366-6999.222324 CrossRefPubMedPubMedCentral

Steelman LS, Pohnert SC, Shelton JG, Franklin RA, Bertrand FE, McCubrey JA (2004) JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis. Leukemia 18:189–218. https://doi.org/10.1038/sj.leu.2403241 CrossRefPubMed

Steinway SN, Loughran TP (2013) Targeting IL-15 in large granular lymphocyte leukemia. Expert Rev Clin Immunol 9:405–408. https://doi.org/10.1586/eci.13.28 CrossRefPubMedPubMedCentral

Thomas SJ, Snowden JA, Zeidler MP, Danson SJ (2015) The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours. Br J Cancer 113:365–371. https://doi.org/10.1038/bjc.2015.233 CrossRefPubMedPubMedCentral

Tinhofer I, Marschitz I, Henn T, Egle A, Greil R (2000) Expression of functional interleukin-15 receptor and autocrine production of interleukin-15 as mechanisms of tumor propagation in multiple myeloma. Blood 95:610–618PubMed

Trinchieri G (1997) Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFN-gamma). Curr Opin Immunol 9:17–23. https://doi.org/10.1016/s0952-7915(97)80154-9 CrossRefPubMed

Trinder P, Seitzer U, Gerdes J, Seliger B, Maeurer M (1999) Constitutive and IFN-gamma regulated expression of IL-7 and IL-15 in human renal cell cancer. Int J Oncol 14:23–31PubMed

Tsujimoto Y, Finger LR, Yunis J, Nowell PC, Croce CM (1984) Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science (New York, NY) 226:1097-1099

Yang WY, Liu CH, Chang CJ, Lee CC, Chang KJ, Lin CT (2006) Proliferative activity, apoptosis and expression of oestrogen receptor and Bcl-2 oncoprotein in canine mammary gland tumours. J Comp Pathol 134:70–79. https://doi.org/10.1016/j.jcpa.2005.07.002 CrossRefPubMed

Zuccari DA, Castro R, Gelaleti GB, Mancini UM (2011) Interleukin-8 expression associated with canine mammary tumors. Genet Mol Res : GMR 10:1522–1532CrossRefPubMed

Titel: Expression of interleukin-15 in canine mammary carcinoma: relationships with histologic grades, Bcl-2, recurrence, and overall survival
verfasst von: Massoud Rezaee Oghazi
Mohsen Maleki
Ahmad Reza Movassaghi
Zahra Kamyabi-Moghaddam
Publikationsdatum: 28.08.2018
Verlag: Springer London
Erschienen in: Comparative Clinical Pathology / Ausgabe 1/2019
Print ISSN: 1618-5641
Elektronische ISSN: 1618-565X
DOI: https://doi.org/10.1007/s00580-018-2813-3

Neu im Fachgebiet Pathologie

01.04.2024 | Forensische Traumatologie | CME

Springer Medizin

Expression of interleukin-15 in canine mammary carcinoma: relationships with histologic grades, Bcl-2, recurrence, and overall survival

Abstract

Neu im Fachgebiet Pathologie

Theoretische Grundlagen von Explosionen und Explosionsverletzungen

Auswirkungen vorgeschalteter Laborprozesse auf die Digitalisierung histologischer Schnittpräparate

Knochenmarkhistologie bei Zytopenien

Herausforderungen der Automation bei der quantitativen Auswertung von Leberbiopsien

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2019

Phylogenetic evaluation of Macrorhabdus ornithogaster isolated from a case of canary (Serinus canaria)

Molecular investigation of Lawsonia intracellularis in diarrheic and healthy captive ostriches (Struthio camelus) in Iran

Applications of fluorescence in situ hybridization in detection of disease biomarkers and personalized medicine

Evaluation of the toxicopathological lesions of Calotropis procera using a chick embryonic model

An immunoturbidimetric assay for bovine haptoglobin

Evaluation of leukocyte esterase test strips for rapid diagnosis of subclinical mastitis in dairy cows

Neu im Fachgebiet Pathologie

Theoretische Grundlagen von Explosionen und Explosionsverletzungen

Auswirkungen vorgeschalteter Laborprozesse auf die Digitalisierung histologischer Schnittpräparate

Knochenmarkhistologie bei Zytopenien

Herausforderungen der Automation bei der quantitativen Auswertung von Leberbiopsien